2024
Buprenorphine Knowledge and Attitudes Among Sickle Cell Disease Providers
Nguemeni Tiako M, Afranie-Sakyi J, Van Doren L, Vasquez K, Calhoun C. Buprenorphine Knowledge and Attitudes Among Sickle Cell Disease Providers. Blood 2024, 144: 2442-2442. DOI: 10.1182/blood-2024-206368.Peer-Reviewed Original ResearchSickle cell diseaseChronic painOpioid analgesicsSide effectsX-waiverPain managementAdequate analgesiaRespiratory depressionTraditional opioidsOff-labelSickle cell disease providerBuprenorphine formulationsImproving provider knowledgeFDA approvalSurvey of providersRisk of respiratory depressionCross-sectional surveyEffective opioid analgesicMedical education opportunitiesOpioid-induced hyperalgesiaSickle cell disease patientsCompared to other opioidsMorphine milligram equivalentsOpioid side effectsAbuse-deterrent technologyBuprenorphine & Sickle Cell: How Pediatric and Adult Providers Differ in Prescribing Habits and Evolving Pain Management Styles
Afranie-Sakyi J, Tiako M, Vasquez K, Van Doren L, Calhoun C. Buprenorphine & Sickle Cell: How Pediatric and Adult Providers Differ in Prescribing Habits and Evolving Pain Management Styles. Blood 2024, 144: 3628. DOI: 10.1182/blood-2024-194039.Peer-Reviewed Original ResearchSickle cell disease providerSCD-related painSickle cell diseaseAdult providersOpioid use disorderPrescribing buprenorphineX-waiverOpioid agonistsPain managementChronic painPrescribing habitsPediatric providersInitiate buprenorphineAdvanced practice providersSCD agesHigh volume of patientsPain management guidelinesSide effectsOptimal pain managementDose-dependent adverse effectsDecreased quality of lifeCross-sectional studyPartial opioid agonistQuality of lifeChronic hemolytic anemia
2023
Standardized Clinical Pathways Improve Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department
Forward J, Thomas D, O'Malley S, Berkwitt A, Calhoun C, Krishnamurti L, Pashankar F. Standardized Clinical Pathways Improve Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department. Blood 2023, 142: 2315. DOI: 10.1182/blood-2023-181285.Peer-Reviewed Original ResearchVaso-occlusive episodesSickle cell diseasePediatric emergency departmentMinutes of arrivalPain managementEmergency departmentClinical pathwayIntranasal fentanylYears post implementationHydromorphone PCAPain medicationPediatric patientsJune 30 thPain medication administrationVaso-occlusive painPercent of patientsPercentage of patientsQuality improvement projectOutcome one yearElectronic medical recordsPost implementationHealth care systemFirst analgesicED visitsED encounters